Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.